Gilead Sciences Stock Analysis

Gilead Stock Analysis Notes

About 88.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.53. Gilead Sciences last dividend was issued on the 13th of December 2024. The entity had 2:1 split on the 28th of January 2013. Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company was incorporated in 1987 and is headquartered in Foster City, California. Gilead Sciences operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 14400 people. To learn more about Gilead Sciences call Daniel ODay at 650 574 3000 or check out https://www.gilead.com.

Gilead Sciences Investment Alerts

Gilead Sciences Upcoming and Recent Events

Gilead Largest EPS Surprises

View All Earnings Estimates

Gilead Sciences Environmental, Social, and Governance (ESG) Scores

Gilead Sciences Thematic Classifications

Gilead Stock Institutional Investors

Note, although Gilead Sciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Gilead Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 115.38 B.

Gilead Profitablity

Management Efficiency

Gilead Sciences has return on total asset (ROA) of 0.1196 % which means that it generated a profit of $0.1196 on every $100 spent on assets. This is way below average. Gilead Sciences' management efficiency ratios could be used to measure how well Gilead Sciences manages its routine affairs as well as how well it operates its assets and liabilities. At present, Gilead Sciences' Return On Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.26, whereas Return On Capital Employed is forecasted to decline to 0.08. At present, Gilead Sciences' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 5 B, whereas Total Current Assets are forecasted to decline to about 10.8 B.

Technical Drivers

As of the 30th of November, Gilead Sciences retains the Downside Deviation of 1.4, risk adjusted performance of 0.1541, and Market Risk Adjusted Performance of 0.5584. Gilead Sciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Gilead Sciences treynor ratio, and the relationship between the variance and potential upside to decide if Gilead Sciences is priced fairly, providing market reflects its last-minute price of 92.58 per share. Given that Gilead Sciences has jensen alpha of 0.2016, we strongly advise you to confirm Gilead Sciences's regular market performance to make sure the company can sustain itself at a future point.

Gilead Sciences Price Movement Analysis

Gilead Sciences Insider Trading Activities

Gilead Sciences Outstanding Bonds

Gilead Sciences Predictive Daily Indicators

Gilead Sciences Corporate Filings

Gilead Sciences Forecast Models

Gilead Sciences' time-series forecasting models are one of many Gilead Sciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Gilead Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Gilead Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Gilead shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Gilead Sciences. By using and applying Gilead Stock analysis, traders can create a robust methodology for identifying Gilead entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Gilead analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Gilead analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Gilead Sciences stock analysis indicators help investors evaluate how Gilead Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Gilead Sciences shares will generate the highest return on investment. By understating and applying Gilead Sciences stock analysis, traders can identify Gilead Sciences position entry and exit signals to maximize returns.

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.